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In human hemochromatosis, tissue toxicity is a function of tissue iron levels. Despite reports of skin toxicity in
hemochromatosis, little is known about iron levels in skin of individuals with systemic iron overload. We measured
skin iron and studied skin histology in three mouse models of systemic iron overload: mice with a deletion of the
hemochromatosis (Hfe) gene, mice fed a high iron diet, and mice given parenteral injections of iron. In Hfe/mice,
iron content in the epidermis and dermis was unexpectedly the same as in Hfeþ /þ mice, and there were no
histological abnormalities detected after 30 wk. A high iron diet produced increased iron in the epidermis of both
normal and Hfe/ animals; a high diet increased iron in the dermis only in Hfe/mice. Increased skin iron was not
associated with other histological changes, even after 19 wk. Parenteral administration of iron produced increased
iron in the epidermis and dermis, and gave the skin a bronze hue. These results show that the amount and
distribution of iron in the skin depends on the etiology of iron overload. It appears that neither Hfe deletion nor
elevated skin iron alone can account for cutaneous manifestations reportedly seen in humans with hereditary
hemochromatosis.
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Skin from humans with hemochromatosis reportedly shows
increased iron (Magnuson and Raulston, 1942), and an ep-
idermis that is hyperkeratotic, atrophic, and pigmented
(Cawley et al, 1969; Chevrant-Breton et al, 1977). These
conclusions are drawn from surveys that made no distinc-
tion between genetic, dietary, or hemolytic causes for hem-
ochromatosis. The textbook descriptions of skin in ‘‘bronze
diabetes’’ are based on these and similar data, which were
accumulated decades ago in patients who often had end-
stage disease. Questions of whether changes in skin were
caused by local effects of iron or by distant effects of iron
toxicity on internal organs were usually not considered, with
the exception of the pigmentary changes (Cawley et al,
1969).
Iron is thought to be a cofactor or mediator of skin tox-
icity in a variety of pathological situations including sunburn
(Bissett et al, 1991), porphyria cutanea tarda (Menon et al,
1991; Takeshita et al, 2004), inflammation (Gira et al, 2003),
and skin cancer (Bhasin et al, 2003). If the amount of tissue
iron is what determines its role in skin toxicity, then it be-
comes critical to know which forms of hemochromatosis
are associated with increased iron in the skin.
Nearly 25% of absorbed iron is normally eliminated from
the body by exfoliation of epidermal cells (Weintraub et al,
1965; Jacob et al, 1981). Yet little is known about the effect
of systemic iron overload on iron in the skin or epidermis.
Although it is now recognized that the regulatory defect re-
sponsible for the most common form of genetic hem-
ochromatosis occurs at the level of iron absorption from
the gut, phenotypic expression of the hemochromatosis
genotype is unexpectedly variable (Pietrangelo, 2004). En-
vironmental and/or additional genetic (Levy et al, 2000; Fle-
ming et al, 2001) influences will certainly account for most of
that variability. Theoretically, variations in the iron accumu-
lation in epidermis and loss through desquamation could
also modulate body stores of iron.
Because of earlier recognition and treatment of hem-
ochromatosis, it may never again be possible to determine
whether different causes of human hemochromatosis result
in the same or different manifestations in skin. Fortunately,
systematic evaluation of the epidermis and skin in hem-
ochromatosis is now possible through the availability of
genetically defined animal models of iron overload (Levy
et al, 1999; Hentze et al, 2004). Inactivation of the Hfe gene
in mice alters iron homeostasis and produces changes in
tissue iron distribution that are similar to changes found in
humans with HFE mutations (Zhou et al, 1998; Levy et al,
1999). In order to identify biochemical and histological
changes in the epidermis that are associated with defined
types of systemic iron overload, we studied the cutaneous
effects of diet, parenteral injection of iron, and inactivation
of the Hfe gene in mice.
Results
Skin in hereditary hemochromatosis In preliminary ex-
periments, we established that the iron content in the ep-
idermis and hair was indistinguishable in male and female
littermates for 129/Sv Hfeþ /þ and 129/Sv Hfe/ mice. By
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contrast, the iron content of internal organs is known to vary
with sex and is generally higher in females than males, a
finding we confirmed in livers of 129/Sv Hfeþ /þ and 129/Sv
Hfe/ mice. Therefore, only females were analyzed for
these longitudinal studies.
Iron content was measured in the epidermis from various
locations in groups of animals ranging in age from 4 to 30
wk (Fig 1). Epidermal iron varied significantly during the first
2 mo of life. It was highest at 4 wk and lowest at 8 wk, at all
locations of the epidermis sampled. Epidermal iron also
varied with location. In adults it was highest in the abdom-
inal (ventral) epidermis and lowest in the tail epidermis. At
most time points and most locations, epidermal iron was
slightly higher in 129/Sv Hfe/ animals than in wild-type
129/Sv Hfeþ /þ animals. But differences in epidermal iron
between hemochromatosis and control animals were very
small and not statistically significant. Iron content of hair
varied over time, but the iron in hair of 129/Sv Hfe/
animals was the same as that in control 129/Sv Hfeþ /þ
animals. Iron in the dermis from which the epidermis and fat
had been removed was the same in 129/Sv Hfe/ mice and
in 129/Sv Hfeþ /þ mice.
Iron in internal organs of our animals showed differences
between Hfeþ /þ mice and Hfe/ mice as previously de-
scribed in the literature (Levy et al, 1999; Lebeau et al, 2002;
Turoczi et al, 2003). Iron in livers of 129/Sv Hfe/ mice was
2–3-fold greater than iron in livers of 129/Sv Hfeþ /þ mice
(Fig 1). Hepatic iron gradually increased in the control an-
imals over time, but in the hemochromatosis animals he-
patic iron reached a plateau at 8–10 wk of age. Comparing
129/Sv Hfe/ mice to 129/SV Hfeþ /þ mice at 30 wk, there
were small, statistically significant increases in the iron in
pancreas (253  9 vs 207  9 mg per g dry wt) and kidney
(742  15 vs 652  18 mg per g dry wt); iron in the hearts of
these groups of animals was the same.
Histological sections from the back, tail, and ear skin
were examined for findings that have been reported in hu-
mans with hemochromatosis: thickening of the stratum
corneum; epidermal atrophy; evidence for iron deposition or
changes in melanin. At 30 wk of age, no differences in the
dorsal epidermis or skin could be identified in H&E (Fig S1a
and b) or Fontana Masson (Fig S1i and j)-stained sections
from 129/Sv Hfe/ mice compared with 129/Sv Hfeþ /þ
mice. In sections stained for iron, there were an increased
number of iron-containing histiocytes in the fat and espe-
cially in the panniculus carnosus in the hemochromatosis
compared with the control animals. In the lower dermis
there was a slight increase in the number of iron-stained
histiocytes in hemochromatosis compared with control an-
imals (Fig S1e and f). Stainable iron was not identified in
fibroblasts or keratinocytes, even in the hemochromatosis
animals. The highly localized collections of increased iron in
the lower dermis were clearly not sufficient to affect the
biochemical content of iron in the dermis (from which fat
and muscle had been removed).
Skin in dietary hemochromatosis In the absence of sig-
nificant changes in the skin of animals with hereditary hem-
ochromatosis, we asked whether dietary iron might
influence the expression of the genotype in the epidermis.
Animals were maintained on either a basal iron or high iron
diet for 5 wk after weaning. The high iron diet resulted in
significantly increased iron in the epidermis and hair in 129/
Sv Hfe/ mice (Fig 2). Surprisingly, similar increases were
observed in 129/Sv Hfeþ /þ mice on the high iron diet (Fig
2). The high iron diet caused a 2–4-fold increase in the iron
content of the epidermis and hair at all sites examined both
in control and in hemochromatosis animals. By contrast, the
high iron diet increased iron only in the dermis of 129/Sv
Hfe/ mice; diet had no effect on dermal iron in the con-
trols. The high iron diet also caused a 2-fold increase in
hepatic iron both in the control and Hfe/ animals.
Animals on the high iron diet had elevated iron in the
epidermis, but had no grossly obvious phenotype com-
pared with animals on the basal iron diet. Animals with in-
creased iron in the epidermis showed no evidence of the
epidermal atrophy or ichthyosiform changes that have been
reported in human hemochromatosis (Fig S1c and d). There
was no stainable iron in the epidermis, but the number of
iron-laden histiocytes in the lower dermis and fat of 129/Sv
Figure 1
Iron content changes over time in skin, but is unaffected by genotype. Iron was measured (mg per g dry weight) in the epidermis and hair,
harvested at various times and from various locations of 129/Sv Hfe/ (solid square or bar) and 129/Sv Hfeþ /þ (open diamond or bar) mice. Each
point represents meanþSEM of eight to 13 female animals. Last panel shows 30 wk measurements from additional tissues and dermis from ventral
(V), tail (T), dorsal (D), and ear (E) skin.
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Hfe/ mice was increased (Fig S1g and h). No gross or
microscopic changes in pigmentation were appreciated (Fig
S1k and l). In a separate experiment, 129/Sv Hfeþ /þ mice
received either a basal iron or high iron diet for 19 wk, to test
whether diet alone would lead to progressive changes in the
skin. Epidermal iron showed the same 2–4-fold increase,
compared with animals on a control diet, as was observed
in the 5 wk diet experiment. Even after 19 wk of elevated
iron in the epidermis there were no identifiable histological
changes in the skin, other than increased iron in histiocytes
(data not shown).
Increased epidermal iron was associated with one ex-
pected biochemical change in these animals. Ferritin, which
was barely detectable in epidermal extracts from animals on
the basal iron diet, was increased in the epidermis of an-
imals on the high iron diet (Fig 3).
Skin in parenteral iron overload Tissue distribution of iron
in secondary hemochromatosis can differ significantly from
that in the common form of hereditary hemochromatosis
(Andrews, 1999), and parenteral injections of iron have been
used to demonstrate toxic effects of iron in skin (Rezazadeh
and Athar, 1997; Bhasin et al, 2003). Hairless animals were
given repeated intraperitoneal injections of iron dextran, and
after several weeks iron was measured in the epidermis,
dermis, and several internal organs. Doses ranged from 0.1
mg per injection, an amount equivalent on the basis of body
mass to that expected in patients with thalassemia major,
to 5 mg per injection, the amount used in experimental
carcinogenesis studies (Rezazadeh and Athar, 1997; Bhasin
et al, 2003). Injections of iron led to a dose-related increase
in iron in all tissues examined (Fig 4). Epidermal iron in-
creased 3–4-fold in animals receiving iron injections com-
pared with control animals, but only at the highest dose
administered. In distinction to Hfeþ /þ mice challenged with
dietary iron overload, dermal iron also increased (4–8-fold)
in animals receiving parenteral iron. The dose response ex-
periment shows that the threshold for tissue iron accumu-
lation was lowest for the liver and spleen, higher for the
dermis and highest for the epidermis.
In sharp contrast to animals with exclusively epidermal
iron overload, animals receiving the higher doses of paren-
teral iron had an obvious bronze or rusty appearance (Fig
5A). Animals receiving 0.1 mg looked no different than con-
trols, but animals receiving more than 1 mg per injection
were bronze colored. Animals with parenterally induced iron
overload had large numbers of iron-laden histiocytes in the
dermis and greatly increased numbers of hemosiderin gran-
ules, which stained positively with Prussian blue (Fig 5B).
These animals had no identifiable histological changes in
the epidermis and no stainable iron in the epidermis. Stain
for melanin showed no difference between controls and
iron-overloaded animals.
Discussion
We produced systemic iron overload in mice by three dif-
ferent methods, and then monitored morphological and bi-
ochemical changes in the skin. The results demonstrate four
chief findings. First, in mice with hereditary hem-
ochromatosis (Hfe/) on a basal iron diet, iron was not
increased in the epidermis and there were no identifiable
histological changes, compared with wild-type littermates.
Second, in mice that got systemic iron overload from diet,
iron was increased in the epidermis of Hfeþ /þ as well as
Hfe/ animals; only Hfe/ animals had increased iron in
the dermis. Third, in mice that got iron overload from par-
enteral injection, iron was increased in the dermis and in the
epidermis. Fourth, 5 mo of chronically elevated iron in the
Figure 2
Supplemental dietary iron increases iron in the epidermis, dermis,
hair, and liver in 129/Sv Hfe/and 129/Sv Hfeþ /þ mice. Animals
were maintained for 5 wk on a normal diet containing 0.226 g per kg
iron (open bars) or on a diet containing 20.226 g per kg iron (closed
bars). Iron measurements in the epidermis, dermis, and hair and liver
are means  SEM from five female animals.
Figure 3
Ferritin increases in the epidermis of 129/Sv Hfe/ mice main-
tained on a high iron diet. Protein extracts from the epidermis of 129/
Sv Hfe/ mice fed on a normal basal diet (lo) or on a high iron diet (hi)
were analyzed for 21 kDa mouse ferritin by western blot. Cross-react-
ing 28 kDa band on this blot serves as internal loading control.
Figure4
Parenteral injections of iron increase iron in the dermis and ep-
idermis of SKH/129/Sv Hfe/ mice. Iron was measured in tissues of
SKH/129/Sv Hfe/ mice that had received biweekly injections of iron
dextran for 2 wk. Data are from groups of five female animals  SEM
saline (&); 0.1 mg ( ); 1 mg ( ); 5 mg (’).
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epidermis caused no identifiable gross or histological
effects on skin.
Quantitative and qualitative considerations both contrib-
ute to the observed differences in cutaneous iron accumu-
lation produced by the three types of systemic iron
overload. Quantity matters: the amount of iron in the diet
was the sole cause of elevated iron in the epidermis of 129/
Sv Hfeþ /þ control animals on the high iron diet. In animals
given parenteral iron, there was a clear threshold below
which iron did not accumulate in either the dermis or ep-
idermis. Quality maters: different causes of systemic iron
overload result in different distributions of skin iron. The
threshold for iron accumulation following parenteral admin-
istration is lower for the dermis than the epidermis. By con-
trast, the threshold for iron accumulation following dietary
overload was lower for the epidermis than the dermis. Pref-
erential accumulation in reticuloendothelial cells of the de-
rmis might account for dermal accumulation following
parenteral injection of iron, similar to reticuloendothelial ac-
cumulation in the spleen after parenteral injections of iron
(Andrews, 1999). One limitation of a biochemical measure of
iron is failure to detect highly localized changes. Clearly in-
creased stainable iron in the histiocytes of Hfe/ animals
on a normal diet was not extensive enough to significantly
increase total iron in the dermis.
The amount of hepatic iron overload does not always
correlate with the amount or location of iron in the skin. He-
patic iron was elevated to about the same extent in Hfe/
animals on a regular diet, in Hfeþ /þ animals on a high iron
diet, and in SKH/129/Sv Hfe/ animals receiving biweekly
injections of 1 mg iron dextran. Yet epidermal iron was el-
evated only in the Hfeþ /þ control animals on a high iron
diet. In these three groups of animals with equal hepatic
iron, dermal iron was increased only in the animals receiving
injections.
These studies are systematic and longitudinal investiga-
tions of skin in animals with systemic iron overload. In ad-
dition, they add to the growing body of evidence indicating
that, in hereditary hemochromatosis, the amount of dietary
iron is an important factor in iron accumulation in tissues,
even in primary target organs such as the liver (Ajioka et al,
2002). Little iron accumulates in the kidneys of Hfe/ani-
mals on a basal iron diet; on a high iron diet both Hfe
/
and
Hfeþ /þ animals have increased iron in their kidneys (Le-
beau et al, 2002). This effect of diet on renal iron is similar to
our findings in the epidermis.
Why do we not see evidence of tissue pathology in the
skin of our animals? Tissue pathology and dysfunction,
which are readily identified in humans with systemic iron
overload, have been more difficult to demonstrate than
simple iron accumulation in Hfe/ mice. Fibrosis is not
seen in the iron-overloaded liver (Lebeau et al, 2002) or
heart (Turoczi et al, 2003) in Hfe/ animals. But in a cardiac
ischemia–reperfusion experiment, injury is exaggerated in
Hfe/ mice on a high iron diet (Turoczi et al, 2003). Sim-
ilarly, Hfe/ mice with hepatic iron overload do not accu-
mulate porphyrins in their livers, unless they also have an
inactivating mutation in one allele of the uroporphyrinogen
decarboxylase gene (Phillips et al, 2001).
Absence of identifiable pathology in our animals that
have increased epidermal iron may simply mean that ad-
ditional factors are needed to reveal the toxic effects of
elevated iron in the epidermis. Parenterally induced iron
overload shortens the time of onset and increases the
number of skin tumors in experimental chemical carcino-
genesis (Rezazadeh and Athar, 1997; Bhasin et al, 2003).
Although iron was increased 3–4-fold in the normal skin of
animals with tumors (Rezazadeh and Athar, 1997; Bhasin
Figure 5
Gross and histological appearance of SKH/129/Sv Hfe/ mice
with iron overload from parentral injections. (A) The hairless, he-
reditary hemochromatosis mouse on the right was given biweekly in-
jections of 5 mg iron dextran for 2 wk. The littermate on the left was
injected with saline. (B) Skin sections from ears were stained with H&E,
Perl’s iron or Fontana Masson. Blue granules of iron are visible only in
the dermis of mice receiving iron injections. Scale bar¼ 250 mm.
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et al, 2003), the reported measurements were of whole skin,
not the epidermis. Our data establish that the parenteral
route of iron administration increases iron in the epidermis
as well as in the dermis.
The findings in skin of mice with systemic iron overload
are not completely concordant with reports of skin changes
in humans with systemic iron overload. In particular, we
were surprised to find no measurable iron accumulation in
skin of mice with hereditary hemochromatosis on a normal
diet. We also could identify no morphological changes in
skin of mice that endured many months of epidermal iron
overload. Most papers that described the ‘‘classic’’ skin
findings in hemochromatosis lump all causes of iron over-
load together. Our data show that the source and mecha-
nism of systemic iron overload is a crucial determinant of
whether iron accumulates in the skin and where in the skin it
will accumulate. In the past, little consideration was given to
additive and complementary roles that diet might have in
hereditary hemochromatosis. In our mice, diet was the crit-
ical determinant of whether iron accumulated in skin in he-
reditary hemochromatosis.
If humans with hereditary hemochromatosis really exhibit
the previously reported changes in skin, then our data pro-
vide good reason to believe that these changes are related
to diet as much as to genetic deficiency of the Hfe protein.
Finally, iron is increased in skin of patients on renal dialysis
(Friedlaender et al, 1988), and clinicians easily recognize the
distinctive pigmentary changes in patients with thalassemia.
Analysis of skin in mice that received parenteral injections of
iron suggests that cutaneous iron distribution from the so-
called secondary hemochromatosis may well be different
from the cutaneous iron distribution in hereditary hemo-
chromatosis.
Materials and Methods
Animals 129/Sv Hfe/ mice have a deletion of exons 3 and 4
(Levy et al, 1999). Control or ‘‘wild-type’’ mice were 129S6/
SvEvTac (‘‘129/Sv’’, Taconic, Germantown, New York). Hairless,
hemochromatosis mice were produced by initially crossing hairless
SKH (Charles River, Wilmington, Massachusetts) with 129/Sv Hfe/
mice. Experiments described here were done using hairless mice
(SKH/129/Sv Hfe/) that were homozygous for the disrupted Hfe
allele and which had been through six generations of brother–sister
inbreeding. All mouse production and experimentation was
performed in compliance with guidelines of the Yale Institutional
Animal Care and Use Committee.
Diet Breeders and control animals in the diet experiments were
fed standard mouse chow (Harlan, Teklad, Madison, Wisconsin)
containing 0.226 g per kg iron (diet TD2018). For the high iron diet,
chow was supplemented with carbonyl iron to bring final iron to
20.226 g per kg (diet TD04,064).
Iron injection Some mice were given iron dextran (NDC 30,798-
020-10, Durvet, Blue Springs, Missouri), 5 mg intraperitoneally two
times each week for 2 wk before analysis.
Genotyping Wild-type Hfe was distinguished from the disrupted
Hfe by 30 cycles of PCR, using Taq polymerase (M1661, Promega,
Madison, Wisconsin) and primers that produce a 202 bp wild-type
band and a 190 bp disrupted band as described (Levy et al, 2000).
Tissue preparation Hair was plucked from regions of skin to
be harvested and saved for analysis. Fat was trimmed from the
dermis, and 1  2 cm pieces of skin were treated overnight in
dispase (Kitano and Okada, 1983) to separate the epidermis from
the dermis. All manipulations were done using iron-free titanium
instruments. The epidermis, dermis, the left lobe of the liver and
whole pancreas, heart, and kidney were rinsed in PBS, then blotted
dry. All tissues were dried overnight at 651C in tared microfuge
tubes.
Iron measurement Non-heme iron in tissues and cells was meas-
ured using the bathophenanthroline sulfonate (BPS, Sigma, St
Louis, Missouri) dye binding assay, originally described by Tor-
rance and Bothwell (1980), and adapted to a microtiter plate for-
mat. In brief, tissue was digested in the 10% (v/w) acid mixture,
and triplicate samples of 12 mL added to wells in 96-well plates
containing 200 mL of BPS. Absorbance was read at 565 nm from
samples and ferric chloride standards representing 0–75 ng of iron.
Histology Tissues were fixed in Bouin’s solution, embedded in
paraffin, sectioned at 5 mm, deparaffinized, and stained with H&E,
Perl’s stain for iron and Fontana Masson stain for melanin.
Western blot for ferritin Total ferritin was estimated by western
blot of protein separated on denaturing gels. Epidermal sheets
were extracted by sonication on ice in 10 mM Tris, pH 7.4 con-
taining 1% SDS and 1 mM dithiothreitol and protease inhibitors.
Protein was measured by a modification of the Bramhall assay
(Milstone et al, 1982), and 20 mg separated by 15% SDS-PAGE.
After protein transfer for 3.5 h at 100 mA, the approximately 21 kDa
ferritin band was identified using a rabbit anti-horse ferritin anti-
body at 1:1750 (F-5762, Sigma), a goat anti-rabbit HRP-antibody
at 1:5000 (NA934, Amersham, Piscataway, New Jersey), and an
ECL kit (RPN2106, Amersham) and X-ray film (870-1302, Eastman
Kodak, Rochester, New York).
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The following material is available online for this article.
Figure S1. History of skin in animals with hereditary and/or dietary
hemochromatosis.
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